Skip to content

SANUWAVE Health, Inc.: 10-Q filed 2019-08-14

What SANUWAVE Health, Inc. reported in its quarterly report filed 2019-08-14 (fiscal Q2 2019): 38 published measures, 107 facts as tagged in accession 0001654954-19-009603.

This filing

Form
10-Q (quarterly report)
Filed
2019-08-14
Fiscal period
fiscal Q2 2019
Accession
0001654954-19-009603 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SANUWAVE Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-06-301,513,076USD
At 2018-12-311,177,728USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-06-3017,868,582USD
At 2018-12-3116,533,827USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-06-30-16,355,506USD
At 2019-03-31-15,693,947USD
At 2018-12-31-15,356,099USD
At 2018-06-30-14,560,166USD
At 2018-03-31-13,935,396USD
At 2017-12-31-9,880,827USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-06-30154,446USD
At 2018-12-31364,549USD
At 2018-06-30670,714USD
At 2017-12-31730,184USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-2,734,431USD91
2019-01-01 to 2019-06-30-4,931,748USD181
2019-01-01 to 2019-03-31-2,197,317USD90
2018-04-01 to 2018-06-30-2,888,259USD91
2018-01-01 to 2018-06-30-8,744,914USD181
2018-01-01 to 2018-03-31-5,856,655USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-3,402,634USD181
2018-01-01 to 2018-06-30-1,598,202USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-06-3025,839USD181
2018-01-01 to 2018-06-3013,612USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-04-01 to 2019-06-30316,976USD91
2019-01-01 to 2019-06-30494,939USD181
2018-04-01 to 2018-06-30453,210USD91
2018-01-01 to 2018-06-30797,482USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-06-303,219,279USD181
2018-01-01 to 2018-06-301,563,313USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-25,839USD181
2018-01-01 to 2018-06-30-13,612USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-06-30-120,254,865USD
At 2018-12-31-116,602,778USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-06-3085,782USD
At 2018-12-3177,755USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-01-01 to 2019-06-3031,758USD181
2018-01-01 to 2018-06-30836,796USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-2,019,515USD91
2019-01-01 to 2019-06-30-3,879,948USD181
2018-04-01 to 2018-06-30-2,121,747USD91
2018-01-01 to 2018-06-30-3,243,007USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-06-301,005,035USD
At 2018-12-311,083,482USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-04-01 to 2019-06-30160,215USD91
2019-01-01 to 2019-06-30308,476USD181
2018-04-01 to 2018-06-301,735,509USD91
2018-01-01 to 2018-06-303,291,265USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-06-3017,528,808USD
At 2018-12-3116,487,091USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-06-301,456,727USD
At 2018-12-311,592,643USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2019-06-30175,041USD
At 2018-12-31234,774USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-04-01 to 2019-06-302,150,610USD91
2019-01-01 to 2019-06-304,095,153USD181
2018-04-01 to 2018-06-302,408,314USD91
2018-01-01 to 2018-06-303,708,380USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-06-30423,932USD
At 2018-12-31357,820USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-04-01 to 2019-06-30131,095USD91
2019-01-01 to 2019-06-30215,205USD181
2018-04-01 to 2018-06-30286,567USD91
2018-01-01 to 2018-06-30465,373USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2019-04-01 to 2019-06-30185,881USD91
2019-01-01 to 2019-06-30279,734USD181
2018-04-01 to 2018-06-30166,643USD91
2018-01-01 to 2018-06-30332,109USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2019-04-01 to 2019-06-30307,273USD91
2019-01-01 to 2019-06-30567,922USD181
2018-04-01 to 2018-06-30328,753USD91
2018-01-01 to 2018-06-30678,197USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-06-30188,650,891shares
At 2018-12-31155,665,138shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-06-30103,774,485USD
At 2018-12-31101,153,882USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-06-30-63,777USD
At 2018-12-31-62,868USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2019-06-30398,698USD
At 2018-12-310USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2019-06-30439,850USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2019-06-3023,561USD
At 2018-12-3116,491USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2019-06-30795,458USD
At 2018-12-31689,280USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-2,732,942USD91
2019-01-01 to 2019-06-30-4,932,657USD181
2018-04-01 to 2018-06-30-2,900,163USD91
2018-01-01 to 2018-06-30-8,755,883USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-301,426,405USD91
2019-01-01 to 2019-06-302,943,860USD181
2018-04-01 to 2018-06-301,911,688USD91
2018-01-01 to 2018-06-302,805,335USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-04-01 to 2019-06-309,455USD91
2019-01-01 to 2019-06-3017,812USD181
2018-04-01 to 2018-06-306,008USD91
2018-01-01 to 2018-06-3011,024USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-714,916USD91
2019-01-01 to 2019-06-30-1,051,800USD181
2018-04-01 to 2018-06-30-766,512USD91
2018-01-01 to 2018-06-30-5,501,907USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-34,485USD181
2018-01-01 to 2018-06-30-69,534USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-06-3066,112USD181
2018-01-01 to 2018-06-30-15,216USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-135,916USD181
2018-01-01 to 2018-06-30-425,489USD181

Inspect the source

Entity
SANUWAVE Health, Inc. / CIK 0001417663
Captured
2026-09-20T08:02:35.518Z
SEC response SHA-256
51a2d5afc6b3c84f5ebe71aa20944ba7646a9b22810a9cc023a45d564e5104f2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001417663.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))